Hepatocellular carcinoma: Spectrum of contrast-enhanced gray-scale harmonic sonography findings

Abdominal Imaging

Volumn 29, Issue 3, 2004, Pages 341-347

  Catalano, O ^a   Lobianco, R ^a   Cusati, B ^a   Siani, A ^a  

^a S Maria delle Grazie Hospital   (Italy)

Author keywords

Liver, hepatocellular carcinoma; Liver, percutaneous ablation therapy; Liver, sonography; Sonography, contrast media; Sonography, technique

Indexed keywords

ECHO CONTRAST MEDIUM; SONOVUE;

ARTICLE; CANCER DIAGNOSIS; CATHETER ABLATION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; ULTRASOUND; ULTRASOUND TRANSDUCER;

EID: 2342562521     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-003-0107-x     Document Type: Article

References (24)

1. Lencioni R, Cioni D, Bartolozzi C (2002) Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 12:151-165
2. Bartolozzi C, Lencioni R (2001) Contrast-specific ultrasound imaging of focal liver lesions. Prologue to a promising future. Eur Radiol 11(suppl 3):13-14
3. Burns PN, Wilson SR, Simpson DH (2000) Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 35:58-71
4. Ding H, Kudo M, Maekawa K, et al. (2001) Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agent. Hepatol Res 21:242-251
5. Kim TK, Choi BI, Han JK, et al. (2000) Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 216:411-417
6. Bauer A, Solbiati L, Wessman N (2002) Ultrasound imaging with SonoVue: low mechanical index real-time imaging. Acad Radiol 9(suppl 1):282-284
7. Lencioni R, Cioni D, Crocetti L, et al. (2002) Ultrasound imaging of focal liver lesions with second-generation contrast agent. Acad Radiol 9(suppl 2):371-374
8. Bertolotto M, Dalla Palma L, Quaia E, et al. (2000) Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 10:1369-1376
9. Numata K, Tanaka K, Kiba T, et al. (2001) Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic images. J Ultrasound Med 20:89-98
10. von Herbay A, Vogt C, Haussinger D (2002) Pulse inversion US in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions. J Ultrasound Med 21:1191-1200
11. Yamamoto K, Shiraki K, Deguchi M, et al. (2002) Diagnosis of hepatocellular carcinoma using digital subtraction imaging with contrast agent, Levovist: comparison with helical CT, digital subtraction angiography, and US angiography. Oncol Rep 9:789-792
12. Strobel D, Raeker S, Martus P, et al. (2003) Phase inversion harmonic imaging versus contrast-enhanced power Doppler US for the characterization of focal liver lesions. Int J Colorectal Dis 18:63-672
13. Meuwly JY, Schnyder P, Gudinchet F, et al. (2003) Pulse-inversion harmonic imaging improves lesion conspicuity during US-guided biopsy. J Vasc Intervent Radiol 14:335-341
14. Skjoldbye B, Pedersen MH, Struckmann J, et al. (2002) Improved detection and biopsy of solid liver lesions using pulse-inversion ultrasound scanning and contrast agent infusion. Ultrasound Med Biol 28:439-444
15. Numata K, Isozaki T, Ozawa Y, et al. (2003) Percutaneous ablation therapy guided by contrast-enhanced US for patients with hepatocellular carcinoma. AJR 180:143-149
16. Ding H, Kudo M, Onda H, et al. (2001) Contrast-enhanced subtraction harmonic US for evaluating treatment response in patients with hepatocellular carcinoma. AJR 176:661-666
17. Ding H, Kudo M, Onda H, et al. (2001) Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 221:721-730
18. Wen YL, Kudo M, Zheng RQ, et al. (2003) Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic US. AJR 181:57-63
19. Esteban JM, Gil J (2002) Therapeutic effect of chemoembolization therapy on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic imaging. Acad Radiol 9(suppl 2):382-383
20. Minami Y, Kubo M, Kawasaki T, et al. (2003) Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic US. AJR 180:703-708
21. Morimoto M, Shirato K, Sugimori K, et al. (2003) Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR 181:65-69
22. Schneider M, Arditi M, Barrau MB, et al. (1995) BRI: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 30:415-417
23. Catalano O, Esposito M, Nunziata A, et al. (2000) Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma. Abdom Imaging 25:607-614
24. Solbiati L, Tonolini M, Cova L (2003) Guidance and control of percutaneous treatments. In: Solbiati L, Martegani A, Leen E, et al. (eds) Contrast-enhanced ultrasound of liver diseases. Springer-Verlag Italia, Milan, pp 103-113